Uptravi Coupons & Savings Card – Discount Prices from $11877.84
My prescription
Edit
1000MCG, Uptravi (30 Tablets)
Select pharmacy
Rite Aid
$11877.84
COUPON PRICE
Walgreens
$12380.08
COUPON PRICEUptravi savings card
Show this card to your pharmacistRite Aid
$11877.84
BIN
ID
PCN
GRP
019876
LH20B2A45A
CHIPPO
LHX
Powered by
More prescriptions for pulmonary hypertension
More prescriptions for pulmonary hypertension
Uptravi dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 200MCG | 30 Tablets | $7634.47 | $254.48 |
| 400MCG | 30 Tablets | $11877.84 | $395.93 |
| 600MCG | 30 Tablets | $11877.84 | $395.93 |
| 800MCG | 30 Tablets | $11877.84 | $395.93 |
| 1000MCG | 30 Tablets | $11877.84 | $395.93 |
| 1200MCG | 30 Tablets | $11877.84 | $395.93 |
| 1400MCG | 30 Tablets | $11877.84 | $395.93 |
| 1600MCG | 30 Tablets | $11877.84 | $395.93 |
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Uptravi Warnings
This document outlines critical safety information and warnings related to the use of this medication. Carefully review the details below, and consult your healthcare provider if you have any concerns or questions.
Pulmonary Edema Risk: Be aware that this medication may contribute to an accumulation of excess fluid in the lungs, known as pulmonary edema. This is potentially indicative of a rare type of pulmonary hypertension. Symptoms to watch for include persistent shortness of breath, fatigue (especially during physical activity), chest pain, and a persistent cough. If you experience these symptoms, seek medical advice promptly. Testing for this rare condition is essential, and discontinuation of Uptravi (selexipag) will be necessary if it is confirmed.
Contraindications: Certain conditions and medications may contraindicate the use of this drug due to serious health risks. It is crucial to consult with your healthcare provider if you are taking medications such as gemfibrozil (Lopid), which may interact with Uptravi (selexipag).
By following these guidelines, patients can ensure they use the medication safely and effectively. Always consult with your healthcare provider for personalized advice and information regarding your treatment plan.
Uptravi Side Effects
When taking this medication, some individuals may experience common side effects such as headaches, diarrhea, nausea, jaw pain, vomiting, pain in the arms or legs, muscle pain, and flushing. These symptoms are generally mild, and if they persist or worsen, it's advisable to consult a healthcare provider for guidance.
There are also other side effects that have been reported, including joint pain, rash, loss of appetite, anemia, and low blood pressure, which might cause dizziness or lightheadedness. While these are less common, it's important to monitor these symptoms closely and seek medical advice if they become severe.
Serious side effects, although rare, demand immediate medical attention. These include signs of an allergic reaction such as skin rash, itching, hives, or swelling of the face, lips, tongue, or throat. If any of these occur, it is crucial to obtain urgent medical care promptly. Always prioritize health and safety by staying informed about potential side effects and maintaining open communication with healthcare providers.
Uptravi Interactions
What happens if you stop taking UPTRAVI?
If a patient stops taking UPTRAVI (selexipag) suddenly, it may lead to a worsening of their pulmonary arterial hypertension (PAH) symptoms. It is important for patients to consult their healthcare provider before making any changes to their medication regimen, as the provider can offer guidance on how to safely discontinue or adjust the medication if necessary.
Is UPTRAVI expensive?
The cost of UPTRAVI can be considered high, as it is a specialized medication used for the treatment of pulmonary arterial hypertension. The price can vary based on factors such as dosage, insurance coverage, and pharmacy location. Patients are encouraged to check with their healthcare provider or insurance company for specific cost information and potential financial assistance programs.
Is UPTRAVI a controlled substance?
Uptravi is not classified as a controlled substance. It is a medication used to treat pulmonary arterial hypertension.
Does UPTRAVI cause weight loss?
Weight loss is not commonly reported as a side effect of UPTRAVI (selexipag). However, patients may experience other side effects, and any unexpected changes in weight should be discussed with a healthcare provider to rule out any underlying issues or to adjust treatment if necessary.
What is UPTRAVI used for?
UPTRAVI is used for the treatment of pulmonary arterial hypertension (PAH) to delay disease progression and reduce the risk of hospitalization. It works by relaxing and widening the blood vessels in the lungs, which helps to lower blood pressure and improve the ability to exercise.